Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.

@article{Rakovitch2017MultigeneEA,
  title={Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.},
  author={Eileen Rakovitch and Sharon Nofech-Mozes and W Rick Hanna and Rinku Sutradhar and Frederick L. Baehner and Dave P. Miller and Cindy Y Fong and Sumei Gu and Alan W. Tuck and Sandip K. Sengupta and Leela Elavathil and Prashant A. Jani and Michel P. Bonin and Martin Chang and Elzbieta A. Slodkowska and Joseph Michael Anderson and Diana B. Cherbavaz and Steven Shak and Lawrence F Paszat},
  journal={Journal of the National Cancer Institute},
  year={2017},
  volume={109 4}
}
BACKGROUND Most women with ductal carcinoma in situ (DCIS) will receive breast-conserving surgery (BCS) and radiation (RT). RT can be omitted for women at low risk of local recurrence (LR). The Oncotype DX DCIS score (DS) predicts LR risk after BCS alone. This study assesses the impact of RT and DS on LR risk. METHODS Population-based cohort analysis of individuals with DCIS treated by BCS ± RT from 1994-2003. Treatment and outcomes were determined by linkage and chart review. We used a… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers